Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides

NCT01645293 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Cologne